INNOVATIVE HEALTH PRACTICES
ID: 355134Type: Forecasted
Overview

Buyer

Agency for International Development (USAID)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Other

Opportunity Category

Continuation

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355134
Timeline
    Description

    The United States Agency for International Development (USAID) is forecasting a grant opportunity titled "Innovative Health Practices" aimed at co-creating and scaling innovative research and development interventions to reduce disease and mortality rates globally. This Broad Agency Announcement (BAA) invites unrestricted organizations and companies to submit Expressions of Interest (EOI) to collaborate on generating novel tools and approaches that enhance health outcomes in low-and-middle-income countries (LMICs). The initiative emphasizes the importance of local partnerships and innovative practices in global health, seeking to leverage diverse expertise and resources to address health challenges effectively. Interested applicants can contact Sharon D. Davis at shdavis@usaid.gov or call 202-567-4755 for further information, with applications expected to follow an addendum to this BAA, which is anticipated to be posted on June 25, 2024.

    Point(s) of Contact
    Sharon D Davis Contracting / Agreement Officer
    (202) 567-4755
    shdavis@usaid.gov
    Files
    No associated files provided.
    Similar Opportunities
    The USAID Global Health Broad Agency Announcement for Research and Development (2018)
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) has issued the Global Health Broad Agency Announcement (BAA) for Research and Development, aimed at fostering innovative solutions to critical global health challenges in developing countries. This BAA invites organizations to collaborate with USAID in co-creating research concepts that address significant health issues, such as maternal and child mortality and the prevention of infectious diseases, without directly soliciting funding proposals. The initiative emphasizes partnerships and cooperative engagements, focusing on the capability of participants to contribute to USAID's health objectives, with evaluations based on potential impact at scale. Interested parties can inquire further by contacting USAID at GH-BAA-2018@usaid.gov, with the BAA remaining open until May 30, 2022, for future Addenda that will provide specific funding information.
    The USAID Global Health Development Innovation Accelerator Broad Agency Announcement
    Active
    Agency for International Development
    The Agency for International Development (USAID) is inviting organizations to participate in the Global Health Development Innovation Accelerator Broad Agency Announcement (BAA), aimed at co-creating and scaling innovative solutions to address critical global health challenges. This initiative encourages a diverse range of eligible applicants, including public and private organizations, non-profits, and institutions of higher education, to submit proposals that demonstrate strong potential impacts on reducing maternal and neonatal mortality, particularly in low- and middle-income countries. The program emphasizes flexibility in partnerships and allows for multiple submissions from applicants, with funding amounts ranging from $250,000 to $2 million, and the application process is strictly time-bound with no extensions available. Interested parties should refer to individual addenda for specific contact information and submission deadlines, as the response dates are established by those addenda.
    The USAID Fighting Ebola BAA
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is seeking innovative solutions through its Broad Agency Announcement (BAA) titled "The USAID Fighting Ebola BAA," aimed at combating the Ebola epidemic. This initiative invites public, private, for-profit, and non-profit organizations, as well as institutions of higher education and international organizations, to co-create and collaborate on practical innovations that enhance healthcare delivery and control the spread of Ebola. The program emphasizes the importance of developing cost-effective technologies to support healthcare workers on the front lines. Interested applicants must submit their expressions of interest by December 1, 2014, at 11:59 PM for consideration in the second round review, and can reach out to USAID at SubmitEbolaEOI@usaid.gov for further inquiries.
    Frontier Health Markets APS
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is inviting submissions for the Frontier Health Markets (FHM) Annual Program Statement (APS), aimed at enhancing global health outcomes related to maternal and child health, HIV/AIDS, and infectious diseases. This cooperative agreement seeks to engage both U.S. and non-U.S. organizations, including public, private, for-profit, and nonprofit entities, as well as institutions of higher education and international organizations, to submit concept papers for potential funding under various rounds of the APS. The initiative is critical for improving local health markets and fostering private sector involvement in health initiatives. Interested applicants can reach out to Jacquelin Bell at jacbell@usaid.gov for further information, with the closing date for submissions set for February 24, 2028.
    DIV ANNUAL APS
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) is inviting applications for the Development Innovation Ventures (DIV) Annual Program Statement (APS), aimed at funding innovative solutions to international development challenges, particularly for impoverished populations in developing countries. This competitive grant opportunity allows a wide range of entities, including individuals and organizations, to apply year-round until October 31, 2025, with funding structured across four stages, from pilot funding of up to $500,000 to large-scale implementation grants of up to $15 million. The program emphasizes the importance of demonstrating innovation impact, cost-effectiveness, scalability potential, and financial sustainability, with successful applicants encouraged to leverage additional support for scaling their solutions. Interested parties can contact Julia S. Banks at jbanks@usaid.gov or by phone at 202-916-2783 for further information, with awards expected to range from $500,000 to $15 million based on the stage of funding.
    Accelerating HIV Vaccine Research and Development in Low- and Middle-Income Countries (LMIC)
    Active
    Agency for International Development
    The United States Agency for International Development (USAID) is seeking expert input through a Request for Information (RFI) aimed at accelerating HIV vaccine research and development in low- and middle-income countries (LMICs). This initiative is designed to gather recommendations on opportunities, challenges, and gaps in HIV vaccine R&D, particularly focusing on collaborative ecosystems, efficient manufacturing, and community engagement. The RFI underscores USAID's commitment to enhancing partnerships and locally-led development in regions significantly impacted by HIV, including outreach to historically black colleges and universities (HBCUs) and minority-serving institutions (MSIs). Interested parties must submit their responses electronically by May 24, 2024, at 5:00 PM EDT, adhering to specific formatting guidelines, and can direct inquiries to Simone Cho at scho@usaid.gov.
    Microbicides Research, Development, and Introduction
    Active
    Agency for International Development
    The U.S. Agency for International Development (USAID) is offering a federal grant opportunity titled "Microbicides Research, Development, and Introduction" aimed at advancing research and innovative activities related to microbicides for HIV prevention. This initiative seeks to support clinical trials and other activities that contribute to the Global Health Initiative's principles, particularly focusing on a woman- and girl-centered approach and strengthening health systems. The funding amounts range from $100,000 to $2,250,000, with no cost-sharing or matching requirements, and interested applicants can contact Kathleen Bumpass at kbumpass@usaid.gov for further information. The closing date for applications is to be determined.
    USAID/Philippines Integrated Health Project
    Active
    Philippines USAID-Manila
    The United States Agency for International Development (USAID) Mission in Manila, Philippines, is forecasting an opportunity for the USAID/Philippines Integrated Health Project, aimed at enhancing health development assistance in the country. This initiative seeks to identify local organizations capable of addressing five Key Health Elements (KHE): Health Systems Strengthening, Family Planning and Adolescent Reproductive Health, Tuberculosis, HIV/AIDS, and Global Health Security. The project is particularly focused on engaging local entities that are majority-owned and managed by Philippine citizens or residents, as USAID aims to build partnerships to improve health outcomes amidst significant challenges exacerbated by global crises and the COVID-19 pandemic. Interested organizations are encouraged to respond to the Sources Sought Notice by providing details on their capabilities and past performance, with responses treated as informational only. For further inquiries, organizations may contact Gracelda M Laspinas at glaspinas@usaid.gov or by phone at 6323014929.
    Augmenting Capacity for Humanitarian Emergencies of Infectious Diseases
    Active
    Agency for International Development
    The Agency for International Development (USAID) is offering a federal grant titled "Augmenting Capacity for Humanitarian Emergencies of Infectious Diseases" aimed at enhancing the preparedness and response capabilities of non-governmental organizations (NGOs) in the face of infectious disease outbreaks. The program seeks to establish standby capacity by improving technical coordination and multi-sectoral responses, particularly in health, nutrition, water, sanitation, and agriculture, to effectively manage humanitarian emergencies. With a total funding ceiling of $8 million for a single award, applicants are required to submit concept notes by April 27, 2018, and can direct inquiries to 720FDA18APS00001@ofda.gov for further clarification on the application process.
    UNIVERSAL HEALTH CARE PROJECT APS
    Active
    Philippines USAID-Manila
    The U.S. Agency for International Development (USAID) Mission in the Philippines is inviting applications for the Universal Health Care Project (UHCP) Annual Program Statement (APS), aimed at enhancing health outcomes for underserved and vulnerable populations in the Philippines. The project focuses on strengthening health systems and improving service delivery in key areas such as tuberculosis (TB), HIV/AIDS, family planning, and global health security, aligning with both U.S. and Philippine health objectives. This initiative is critical for addressing systemic health challenges exacerbated by the COVID-19 pandemic and aims to foster collaboration among local and international organizations to build a more resilient health system. Interested applicants can submit concept papers until July 31, 2025, with an expected six awards to be made, and should direct inquiries to Howard Weston at manila-roaa-rfa@usaid.gov.